AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jan 21, 2016
5262_dirs_2016-01-21_7ecd95ae-5a03-4f52-beac-565764d360c7.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6262M
GlaxoSmithKline PLC
21 January 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 21 January 2016, of changes in the interests of the following Persons Discharging Managerial Responsibilities ('PDMR'), following increases in their notional interests in Ordinary Shares, at a price of 1372.50 pence per Share, on the re-investment of dividends paid on 14 January 2016, on Ordinary Shares held in the GlaxoSmithKline Deferred Investment Award Programme.
| PDMR | Ordinary Shares |
| Mr R G Connor | 416.747 |
| Mr S A Hussain | 520.934 |
| Mr D S Redfern | 416.747 |
| Ms C Thomas | 416.747 |
| Dr P J T Vallance | 520.934 |
| Ms E Walmsley | 737.963 |
| Mrs V A Whyte | 59.217 |
V A Whyte
Company Secretary
21 January 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZFLFLQFFXBBV